Basic Information
Partex AI, officially registered as Partex NV, is a global technology company in the biopharmaceutical field with an artificial intelligence platform at its core. The company focuses on leveraging cutting-edge AI technology to empower the entire drug development cycle, from early target discovery, small molecule/antibody drug design, to late-stage clinical trial optimization and commercialization of drug assets. Its core business is to provide a robust AI-driven platform aimed at accelerating drug discovery, optimizing its clinical potential, and efficiently managing licensing transactions worldwide.